Ahn H S, Lee H J, Yoo M W, et al. Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period [J].Br J Surg, 2011, 98(2): 255-260.
[4]
Ferlay J,Colombet M,Soerjomataram I,et al.Estimating the global cancer incidence and mortality in 2018:GLOBOCAN sources and methods[J].Int J Cancer, 2019, 144(8): 1941-1953.
Kim W, Kim H H, Han S U, et al. Korean Laparo-endoscopic Gastrointestinal Surgery Study(KLASS)Group. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for Stage I gastric cancer:Short-term outcomes from a multicenter randomized controlled trial(KLASS-01)[J].Ann Surg,2016,263(1):28-35.
[8]
Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer:a randomized controlled trial[J].J Clin Oncol,2016,34(12):1350-1357.
[9]
Watnabe M, Miyata H, Gotoh M, et al. Total gastrectomy risk moldel: data from 20,011 Japanese patients in a nationwide internet-based database[J]. Ann Surg, 2014,260(6):1034-1039.
[10]
Yang J, Zhang X H, Huang Y H, et al. Diagnosis and treatment of abdominal arterial bleeding after radical gastrectomy: a retrospective analysis of 1875 consecutive resections for gastric cancer[J].J Gastrointest Surg, 2016, 20(3): 510-520.
Tsou C C, Lo S S, Fang W L, et al. Risk factors and management of anastomotic leakage after radical gastrectomy for gastric cancer[J]. Hepatogastroenterology, 2011, 58(105): 218-223.
[13]
Shu X, Ji J, Li X. Cancer risk among patients hospitalized for Type1 diabetes mellitus:apopulation- based cohort study in Sweden [J]. Diabet Med, 2010, 27(7):791-797.
[14]
Brem H, Tomic- Canic M. Cellular and molecular basis of wound healing in diabetes [J]. J Clin Invest, 2007, 117(5): 1219-1222.
[15]
Suding P, Jensen E, Abramson M A, et al. Definitive risk factors for anastmotic leaks in elective open colonrectal resection [J]. Arch Surg, 2008, 143(9): 907-912.
[16]
Onodera H, Ikeuchi D, Nagayama S, et al. Weakness of anastomotic site in diabetic rats is caused by cha Nges in the integrity of newly formed collagen [J]. Dig Surg, 2004, 21(2):146-151.
Fujitani K, Ajani J A, Crane C H, et al. Impact of induction che motherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocar cinoma of the stomach or gastroesophageal junction[J]. Ann Surg Oncol, 2007, 14(7): 2010-2017.
[19]
Sun C, Zhou L Q, Shao X Z, et al. The influence of hypoalbuminemia on postoperative complications of esophageal cancer[J]. Hebei Med, 2015, 21(4): 570-573.
[20]
Kodera Y, Sasako M, Yamamoto S, et al. Identification of risk factors for the development of complications following extended and super-extended lymphadenectomies for gastric cancer[J].Br J Surg,2005,92: 1103-1109.
[21]
Lo C H, Chen J H, Wu C W, et al. Risk factors and management of intra-abdominal infection after extended radical gastrectomy[J].Am J Surg, 2008, 196:741-745.
[22]
Yasuda K, Shiraishi N, Adachi Y, et al. Risk factors for complications following resection of large gastric cancer[J].Br J Surg,2001,88(6): 873-877.
[23]
Nagasako Y, Satoh S, Isogaki J, et al. Impact of anastomotic complications on outcome after laparoscopic gastrectomy for early gastric cancer[J]. Br J Surg, 2012, 99(6): 849-854.
Deguchi Y, Fukagawa T, Morita S, et al.Identification of risk factors for esophagojejunal anastomotic leakage after gastric surgery[J].World J Surg, 2012, 36:1617-1622.
[26]
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3)[J]. Gastric Cancer, 2011, 14(2): 113-123.
Oshi M, Kunisaki C, Miyamoto H, et al. Risk factors for anastomotic leakage of esophagojejunostomy after laparoscopy- assisted total gastrectomy for gastric cancer[J]. Dig Surg, 2017, 35(1):28-34.
[29]
Usui S, Tashiro M, Haruki S, et al. Spleen preservation versus splenectomy in laparoscopic total gastrectomy with D 2 lymphadenectomy for gastric cancer: a comparison of short-term outcomes[J]. Asian J Endosc Surg, 2016, 9(1):5-13.
Mazaki T, Ebisawa K. Enteral versus parenteral nutrition after gastrointestinal surgery: a systematic review and meta-analysis of randomized controlled trials in the English literature[J].J Gastrointest Surg,2008,12(4):739-755.
[40]
Portanova M. Successful enteral nutrition in the treatment of esophagojejunal fistula after total gastrectomy in gastric cancer patients[J]. World J Surg Oncol, 2010, 8:71.
[41]
Cheng Ying, Zhang Junfeng, Zhang Liwei, et al.Enteral immunonutrition versus enteral nutrition for gastric cancer patients undergoing a total gastrectomy: a systematic review and meta-analysis [J].BMC Gastroenterology,2018,18:11.
Arends J, Bachmann P, Baracos V, et al. Espen guidelines on nutrition in cancer patients[J].Clin Nutr,2017,36(1):11-48.
[44]
August D A, Huhmann M B. Directors ASFPAEN Clinical Guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation [J]. JPEN J Parenter Enteral Nutr, 2009, 33(5):472-500.
2021, Vol. 32 
